Want to see NSPR full AI Analyst Report?
InspireMD (NSPR) Stock Statistics & Valuation Metrics
Total Valuation
InspireMD has a market cap or net worth of $32.36M. The enterprise value is $31.87M.
- Market Cap
- $32.36M
- Enterprise Value
- $31.87M
Share Statistics
InspireMD has 46,489,117 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 46,489,117
- Owned by Insiders
- 20.47%
- Owned by Institutions
- 1.01%
Financial Efficiency
InspireMD’s return on equity (ROE) is -0.88 and return on invested capital (ROIC) is -82.18%.
- Return on Equity (ROE)
- -0.88
- Return on Assets (ROA)
- -0.70
- Return on Invested Capital (ROIC)
- -82.18%
- Return on Capital Employed (ROCE)
- -0.84
- Revenue Per Employee
- 70.70K
- Profits Per Employee
- -384.14K
- Employee Count
- 127
- Asset Turnover
- 0.13
- Inventory Turnover
- 1.86
Valuation Ratios
The current PE Ratio of InspireMD is -1.44. InspireMD’s PEG ratio is -0.03.
- PE Ratio
- -1.44
- PS Ratio
- 3.06
- PB Ratio
- 1.66
- Price to FCF
- -0.78
- Price to Operating Cash Flow
- -1.27
- PEG Ratio
- -0.03
Income Statement
In the last 12 months, InspireMD had revenue of 8.98M and earned -48.79M in profits. Earnings per share was -0.76.
- Revenue
- 8.98M
- Gross Profit
- 2.65M
- Operating Income
- -49.11M
- Pretax Income
- -48.72M
- Net Income
- -48.79M
- EBITDA
- -48.25M
- Earnings Per Share (EPS)
- -0.76
Cash Flow
In the last 12 months, operating cash flow was -41.21M and capital expenditures -1.25M, giving a free cash flow of -42.46M billion.
- Operating Cash Flow
- -41.21M
- Free Cash Flow
- -42.46M
- Free Cash Flow per Share
- -0.58
Dividends & Yields
InspireMD pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -126.94%
- Earnings Yield
- -72.84%
Stock Price Statistics
- Beta
- -0.42
- 52-Week Price Change
- -64.49%
- 50-Day Moving Average
- 0.64
- 200-Day Moving Average
- 1.04
- Relative Strength Index (RSI)
- 61.28
- Average Volume (3m)
- 171.49K
Important Dates
InspireMD upcoming earnings date is Nov 12, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Aug 17, 2026
- Next Earnings Date
- Nov 12, 2026
- Ex-Dividend Date
- ―
Financial Position
InspireMD as a current ratio of 5.74, with Debt / Equity ratio of 5.96%
- Current Ratio
- 5.74
- Quick Ratio
- 5.42
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.12
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, InspireMD has paid 63.00K in taxes.
- Income Tax
- 63.00K
- Effective Tax Rate
- -0.00
Enterprise Valuation
InspireMD EV to EBITDA ratio is -0.54, with an EV/FCF ratio of -0.48.
- EV to Sales
- 1.87
- EV to EBITDA
- -0.54
- EV to Free Cash Flow
- -0.48
- EV to Operating Cash Flow
- -0.49
Balance Sheet
InspireMD has $30.42M in cash and marketable securities with $1.97M in debt, giving a net cash position of $28.45M billion.
- Cash & Marketable Securities
- $30.42M
- Total Debt
- $1.97M
- Net Cash
- $28.45M
- Net Cash Per Share
- $0.61
- Tangible Book Value Per Share
- $0.43
Margins
Gross margin is 18.05%, with operating margin of -494.03%, and net profit margin of -355.17%.
- Gross Margin
- 18.05%
- Operating Margin
- -494.03%
- Pretax Margin
- -354.59%
- Net Profit Margin
- -355.17%
- EBITDA Margin
- -349.26%
- EBIT Margin
- -354.59%
Analyst Forecast
The average price target for InspireMD is $3.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $3.50
- Price Target Upside
- 402.87% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- 53.42%
- EPS Growth Forecast
- 22.08%
Scores
- Smart Score
- 4
- AI Score
- 51
